Navigation Links
InterCure Announces 100,000th RESPeRATE Unit Sold
Date:1/24/2008

Awareness and Adoption of Safe, Non-Drug Option to Lower Blood Pressure

Accelerates

NEW YORK, Jan. 24 /PRNewswire/ -- InterCure, Ltd. (Tel Aviv Stock Exchange: INCR) manufacturer of the RESPeRATE(R) hypertension treatment device, clinically-proven to significantly lower blood pressure, today announced it sold its 100,000th RESPeRATE device during the 2007 holiday season. This milestone marks a period of widespread consumer adoption and physician support for the novel technology and provides strong momentum for the RESPeRATE launch into retail pharmacies planned for later this year.

It took approximately four years to generate the first 50,000 unit sales of RESPeRATE, as clinical evidence, physician advocacy and consumer awareness began to take hold following the OTC clearance of the device. The second 50,000 units were sold in just 15 months. Growth is being driven through increased traction in the U.S. direct-to-consumer and online retail channels.

RESPeRATE has driven record volume through the world's leading e-commerce provider, Amazon.com, providing insight into the brand's sales potential within the retail environment. "RESPeRATE was among the top 100 items in our health and personal care store this holiday season," said Brett Barrilleaux, senior buyer at Amazon.com. "The brand's growth this year underscores our shoppers' desire for non-drug solutions in hypertension management."

"InterCure is experiencing robust growth in our core direct-to-consumer and online retail businesses. This reflects the growing consumer adoption rate for the RESPeRATE device and will serve us well as we expand our distribution into chain drugstores," said Erez Gavish, president and CEO of InterCure, manufacturer of the RESPeRATE device. "This year, we have been able to lay a solid foundation for our next phase of growth. Our traditional DTC business is healthier than it has ever been, and we have now assembled a world
'/>"/>

SOURCE InterCure, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
2. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
3. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
4. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
5. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
6. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
7. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
8. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
9. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
10. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
11. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... , July 29 Shionogi Inc., a ... the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), ... from chronic severe drooling associated with neurologic conditions such as ... FDA. , , ... "The FDA approval of CUVPOSA provides parents and caregivers ...
(Date:7/29/2010)... July 29 AVANIR Pharmaceuticals, Inc. ... release unaudited fiscal third quarter financial results for the ... before market open on Thursday, August 5, ... Randall Kaye , M.D., Senior Vice President and ... President, Finance, will host an investment community conference call ...
(Date:7/29/2010)... China , July 29 /PRNewswire-Asia/ -- Winner ... Company"), a leading manufacturer of medical,dressings, medical disposables and ... announced today that it opened its,first online PurCotton(R) store ... http://purcotton.mall.taobao.com/ . , ... ...
Breaking Medicine Technology:Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 2Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 3Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 4AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call 2Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 2Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 3Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 4Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 5Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17 2009 14051 1Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17 2009 14051 2The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 1The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 2The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 3Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 1Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 2Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 3Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 4Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 5
... validate efficacy of the processTHOUSAND OAKS, Calif., Feb. 24 ... successfully completed the initial primate trials validating the efficacy ... in spinal fusion surgery. 100% fusion was obtained ... was observed. The company is currently preparing Pre-IDE ...
... Feb. 24 BioTrends is pleased to announce the fielding of ... (R) . Takeda Pharmaceutical Company Limited announced that they ... febuxostat) on February 13, 2009. Uloric (R) ... and represents the first product for gout that has been approved ...
Other Medicine Technology:Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2
(Date:7/29/2010)... for the first time a cell-of-origin for human ... better predictive and diagnostics tools and the development ... the disease. , The researchers, from UCLA,s Jonsson ... in benign prostate tissue could become human prostate ... finding that bucks conventional wisdom. It had been ...
(Date:7/29/2010)... N.Y. -- Hockey fans likely would assume that body-checking ... causes the most injuries in youth ice hockey. But ... study, the largest and most comprehensive analysis to date ... overall injuries were caused by accidentally hitting the boards ... by a puck. , Only 34 percent of the ...
(Date:7/29/2010)... publishing the mnemonic "ABCD" to facilitate the early diagnosis ... moniker says early detection remains a key factor in ... and colleagues from the Ronald O. Perelman Department of ... that, despite all of the advances in melanoma diagnosis, ... critical. Their report appears online on CA First Look, ...
(Date:7/29/2010)... Amanda Gardner HealthDay Reporter , , WEDNESDAY, July 28 ... able to grow an entire joint from stem cells, albeit ... rabbits were able to hop and walk and bear weight, ... of a paper published online July 29 in The ... joint with restored functioning." If replicated in humans, the ...
(Date:7/29/2010)... Public immunization efforts may be much more sensitive than ... or risks of vaccination, scientists at Harvard University report ... avoidance via social networks can make the difference between ... as large. , The finding, published in Proceedings ... of the worst pertussis outbreaks in 50 years, in ...
Breaking Medicine News(10 mins):Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 2Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 3Health News:Most youth hockey injuries caused by accidents, not checking, UB study shows 2Health News:The evolution of melanoma diagnosis: 25 years beyond the ABCDs 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 3Health News:Small increases in vaccine cost can cause large gaps in protection 2
... Dec. 13 Robert Klaus, President and CEO ... an Outstanding,Public Advocacy Award from the Friends of ... "Robert Klaus,s contributions on behalf of oral ... country," said Peter Anas,Executive Director, NIDCR. "He has ...
... for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA CLARA, Calif., Dec. ... a new network,infrastructure to support a trust-wide Picture Archiving ... Hospitals, part,of the NHS Foundation Trust in Essex, United ...
... Exchange(R),(Amex(R)) today lists the common stock and units of ... QGP.U. One unit consists of three shares of,common stock, ... Warrants,(QGP.WS.B). The common stock and units will be listed ... a later date upon separation of the,unit., The ...
... The chances of infection are boosted 50-fold to 100,000-fold, study ... discovery that perplexes HIV experts, an international team reports that ... of the virus to do its damage. , According to ... , the fibers capture the virus and then ferry it ...
... shows blocking this dependence could stop disease before it ... to certain growth factors contributes to the development of ... activation of a normally silent gene, scientists say. , ... blocking this addiction might help prevent cancer growth. ...
... to see, the mammalian eye also detects light for a ... the timing of the sleep/wake cycle, which is synchronized by ... hypothalamus. , In a study published online on December ... humans whose non-visual responses to light remain intact, suggesting that ...
Other Medicine News:Health News:Oral Health America's Robert Klaus Honored for Outstanding Public Advocacy 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc. 2Health News:Fibers in Semen Help HIV Penetrate Cells 2Health News:Cell 'Addiction' to Growth Factors May Help Spur Cancers 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: